{"id":"https://genegraph.clinicalgenome.org/r/2de73f9c-cad9-4514-a015-a627405a2b65v2.0","type":"EvidenceStrengthAssertion","dc:description":"The TNNI3 gene was originally evaluated for DCM by the ClinGen DCM GCEP on 05/22/2020 for autosomal dominant DCM. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on 3/7/2025. As a result, the classification changed. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein. Human genetic evidence supporting this gene-disease relationship includes case-level data. At least 17 variants have been reported in humans with DCM with the vast majority being missense variants. In addition, this gene-disease assertion is supported by expression studies, in vitro functional assays, protein interaction studies and studies showing rescue in patient cells (PMID: 2226790, 19590045, 29093449, 28436080, 36157491).\n\nIn summary, there is strong evidence to support the relationship between TNNI3 and AD DCM. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 4/18/2025 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/2de73f9c-cad9-4514-a015-a627405a2b65","GCISnapshot":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023","calculatedEvidenceStrength":"Strong","changes":[{"id":"cg:otherTextChange"},{"id":"cg:newEvidence"},{"id":"cg:sopChange"},{"id":"cg:classificationChange"},{"id":"cg:summaryChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-04-18T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-09-04T15:08:50.704Z","role":"Publisher"}],"curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79d69879-ae24-4aa1-af6c-56712a1caabd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79d69879-ae24-4aa1-af6c-56712a1caabd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27532257","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1e8aa9a-3578-4dfa-945f-dd6397516645","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.470C>T (p.Ala157Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021720"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad6a77db-5276-478a-a621-a883801e6052_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","rdfs:label":"TNNI3-Asn185Lys","family":{"id":"https://genegraph.clinicalgenome.org/r/ad6a77db-5276-478a-a621-a883801e6052","type":"Family","rdfs:label":"TNNI3-Asn185Lys","member":{"id":"https://genegraph.clinicalgenome.org/r/1c32061f-c129-4b71-bf95-8d7b0a458abb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","rdfs:label":"II:1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":24,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8d7c8cbe-f291-451b-9548-617e6fda1d4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.555C>G (p.Asn185Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021902"}},"detectionMethod":"Candidate gene sequencing of TNNI3","firstTestingMethod":"Genotyping","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/643ede80-a283-4af4-8d25-588855ec02b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d7c8cbe-f291-451b-9548-617e6fda1d4f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/1c32061f-c129-4b71-bf95-8d7b0a458abb"}},{"id":"https://genegraph.clinicalgenome.org/r/090174ea-959e-4e2b-a5e8-7a32b96f6a86_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","rdfs:label":"TNNI3-Lys36Gln Family","family":{"id":"https://genegraph.clinicalgenome.org/r/090174ea-959e-4e2b-a5e8-7a32b96f6a86","type":"Family","rdfs:label":"TNNI3-Lys36Gln Family","member":{"id":"https://genegraph.clinicalgenome.org/r/ba4aefc5-a122-4d57-9d43-9b41633a1baa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","rdfs:label":"III:2","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f5bcc871-a214-4ceb-8769-c009a320fe15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.106A>C (p.Lys36Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021239"}},"detectionMethod":"candidate sequencing of TNNI3","firstTestingMethod":"Genotyping","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ab6a0526-abf7-43ab-8c79-669bdb2c5a9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5bcc871-a214-4ceb-8769-c009a320fe15"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ba4aefc5-a122-4d57-9d43-9b41633a1baa"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b69cccb4-6e01-4b02-a307-0874dd354893","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b69cccb4-6e01-4b02-a307-0874dd354893_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20215591","allele":{"id":"https://genegraph.clinicalgenome.org/r/96a8c2d4-b0ab-4f16-94b0-174755393fee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.539A>G (p.Asp180Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16609776"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1c08e450-0e2f-4d1a-a326-e73ee3ed966b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c08e450-0e2f-4d1a-a326-e73ee3ed966b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27532257","allele":{"id":"https://genegraph.clinicalgenome.org/r/de238258-71f4-471c-b1e9-317212a06032","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.557G>A (p.Arg186Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021907"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/35f8756a-16a6-4eea-a7b5-3bb5c36eafd6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35f8756a-16a6-4eea-a7b5-3bb5c36eafd6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20215591","allele":{"id":"https://genegraph.clinicalgenome.org/r/96a8c2d4-b0ab-4f16-94b0-174755393fee"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1ca08ee1-30c8-4f0b-826e-d57124a954bc","type":"EvidenceLine","dc:description":"1.0 point assigned for de novo, reduced from the default 2.0 as recommended by ClinGen protocol because it is a missense variant and not a null variant per original curation with SOP v7","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ca08ee1-30c8-4f0b-826e-d57124a954bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31568572","allele":{"id":"https://genegraph.clinicalgenome.org/r/cbb734ed-291e-42ba-9920-b80cc8859c25","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.582C>A (p.Asn194Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407439583"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/913b4fbd-c331-444a-98e1-c4642c001c63","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/913b4fbd-c331-444a-98e1-c4642c001c63_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21846512","allele":{"id":"https://genegraph.clinicalgenome.org/r/eccdf4b9-3ec4-4c1d-9d63-0e1de40184a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.347C>G (p.Ala116Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA051291"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/80202f97-745f-41b3-afb8-c226bfa45555","type":"EvidenceLine","dc:description":"Variant was assigned 1 pt (de novo missense variant), reduced from 1 pt default score from initial curation with SOP v7","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80202f97-745f-41b3-afb8-c226bfa45555_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464770","allele":{"id":"https://genegraph.clinicalgenome.org/r/f1c7800d-1b39-4c8c-8d3d-f810b85449a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.550G>A (p.Glu184Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021885"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/643ede80-a283-4af4-8d25-588855ec02b5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/643ede80-a283-4af4-8d25-588855ec02b5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/643ede80-a283-4af4-8d25-588855ec02b5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of Ca2+ regulation of actin-tropomyosin–activated myosin ATPase by troponin revealed that troponin reconstituted with either mutant troponin I gave lower maximum ATPase rates and lower Ca2+ sensitivity than wild type. Furthermore, mutant thin filaments had reduced Ca2+ affinity compared with normal. The Asn185Lys variant cause DCM and are likely to act via a similar pathogenic mechanism to the DCM mutations reported in other thin filament proteins.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fc5abdc0-169b-4563-be74-a989a462ef66","type":"EvidenceLine","dc:description":"Variant was assigned 1 pt (de novo missense variant), reduced from 1 pt default score from initial curation with SOP v7","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc5abdc0-169b-4563-be74-a989a462ef66_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22464770","allele":{"id":"https://genegraph.clinicalgenome.org/r/47f3062e-7817-48d8-b946-921a07699ae4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.544G>A (p.Glu182Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021848"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/def62961-ec21-4ab0-89fc-172ef2895fdf","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/def62961-ec21-4ab0-89fc-172ef2895fdf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36252119","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5bcc871-a214-4ceb-8769-c009a320fe15"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/def62961-ec21-4ab0-89fc-172ef2895fdf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data from PMID:19590045","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/04293f55-71b5-419b-902b-20322a0634dd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04293f55-71b5-419b-902b-20322a0634dd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c4a54c6-b04c-4625-ba7e-d12cb897b201","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.356C>A (p.Thr119Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021520"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8d9ccb29-afe7-4a7c-a737-aa0866e28fab","type":"EvidenceLine","dc:description":"Variant upgraded to 0.5 due to being previously seen de novo","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d9ccb29-afe7-4a7c-a737-aa0866e28fab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35838873","allele":{"id":"https://genegraph.clinicalgenome.org/r/47f3062e-7817-48d8-b946-921a07699ae4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ab6a0526-abf7-43ab-8c79-669bdb2c5a9d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab6a0526-abf7-43ab-8c79-669bdb2c5a9d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ab6a0526-abf7-43ab-8c79-669bdb2c5a9d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Analysis of Ca2+ regulation of actin-tropomyosin–activated myosin ATPase by troponin revealed that troponin reconstituted with either mutant troponin I gave lower maximum ATPase rates and lower Ca2+ sensitivity than wild type. Furthermore, mutant thin filaments had reduced Ca2+ affinity compared with normal. The Lys36Gln variant cause DCM and are likely to act via a similar pathogenic mechanism to the DCM mutations reported in other thin filament proteins.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4c9185d7-271f-4e9b-ad4e-bfdc78bfde00","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c9185d7-271f-4e9b-ad4e-bfdc78bfde00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36252119","allele":{"id":"https://genegraph.clinicalgenome.org/r/72ed48b5-ef9b-483f-93bc-be6560455a2f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.128C>T (p.Ala43Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407442418"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6cb8ff46-341f-49b7-8bac-e8887486f975","type":"EvidenceLine","dc:description":"Score reduced from default due to missense variants being more common than truncating variants in AD disease","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cb8ff46-341f-49b7-8bac-e8887486f975_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28436080","allele":{"id":"https://genegraph.clinicalgenome.org/r/b6f5775b-faf7-4786-8bc4-976b73602942","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.292C>T (p.Arg98Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021463"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6cb8ff46-341f-49b7-8bac-e8887486f975_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"xpression of TNNI3 reduced in cardiomyocytes of human LV tissue with p.98truncation; Pure haploinsufficiency, increased Ca2+ sensitivity, and impaired length dependent activation also observed; upon exchange of all function deficits, sample was normalized to control values,  [PMID 28436080]","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c215b317-57b5-479b-9669-a1fe1ad43b13","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c215b317-57b5-479b-9669-a1fe1ad43b13_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/d9af3f54-ec0d-4874-9340-265b58a0357d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.488C>T (p.Ala163Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA021757"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3b8911c4-c9da-4b99-8963-c2ce50dc8c5e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b8911c4-c9da-4b99-8963-c2ce50dc8c5e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34036930","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4c72f5d-109d-42ec-85a1-3585d076c12c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.610C>T (p.Arg204Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA022054"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ce85227c-02cf-4d18-8cd9-a3594cf35d8d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce85227c-02cf-4d18-8cd9-a3594cf35d8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f7751c4-4713-4b7e-9bd3-218e55ee0f32","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.596G>A (p.Ser199Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA022024"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/20c83be1-8185-4021-a8e5-bc1cffa13fc4","type":"EvidenceLine","dc:description":"Variant not scored due to presence of LMNA c.868G>A","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20c83be1-8185-4021-a8e5-bc1cffa13fc4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34213952","allele":{"id":"https://genegraph.clinicalgenome.org/r/c6e615e4-4868-49f2-813d-d919106953a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.178G>A (p.Glu60Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407441969"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a5306bf0-409c-4774-820e-adf099980a00","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5306bf0-409c-4774-820e-adf099980a00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26406308","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5bcc871-a214-4ceb-8769-c009a320fe15"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a5306bf0-409c-4774-820e-adf099980a00_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant has been functionally characterized and showed features of pathogenecity in Carballo et. al 2009 (PMID: 19590045)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bc952ca6-cc30-4df7-ac2e-df9ff1d0254d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc952ca6-cc30-4df7-ac2e-df9ff1d0254d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24503780","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c4a54c6-b04c-4625-ba7e-d12cb897b201"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b3f07b5f-c09d-4a8d-acbe-2780aabf901c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b3f07b5f-c09d-4a8d-acbe-2780aabf901c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20817590","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b868a08-c9f9-4361-b724-718083057b48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.46C>A (p.Pro16Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407443150"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f54af29a-e725-4f09-830d-53bc83f19a36","type":"EvidenceLine","dc:description":"Rare missense variant upgraded due to same AA change as seen in other patients","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f54af29a-e725-4f09-830d-53bc83f19a36_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35838873","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3898d3c-ec5e-4cfe-b6a9-319d00da190d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000363.5(TNNI3):c.545A>T (p.Glu182Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA407440193"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.95},{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24d62c5e-b41a-4422-82ae-25320de92e6c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f565a3c-553f-4fb4-9979-b9d35692082d","type":"Finding","dc:description":"The TNNI3p.98trunc patient showed reduced expression of troponin I to 39% (Figure 3D), troponin T to 64%, and troponin C to 73%, and altered stoichiometry between the three cardiac troponin subunits.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28436080","rdfs:label":"single membrane-permeabilized cardiomyocytes in human LV","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/baaacd63-b042-4820-85c4-4d30e730b959","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c25f5a4-9f70-431b-ae61-8a06a3fcf72c","type":"Finding","dc:description":"Expression in fetal heart, postnatal heart, and adult ventricular muscle but not in adult skeletal muscle.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2226790","rdfs:label":"Northern blot","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6cd9bd64-7296-40b4-b73c-7975824c045d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e922e39c-cfa1-493f-8159-326c084db543","type":"Finding","dc:description":"Previous experimental evidence has shown impaired calcium regulation in Ctnl models of heart failure, but the interaction with Atp2a2 and downregulated SERCA2a enzyme is novel evidence","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36157491","rdfs:label":"Lu_interaction","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5bd93705-1bc8-453a-a9a9-afbbbc13b52c","type":"EvidenceLine","dc:description":"Autosomal recessive inheritance pattern with limited evidence","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3c58982-9ffd-4d96-8600-e6ae11658bff","type":"Finding","dc:description":"The effect of the mutation on cTnI, cTnT, and cTnC protein interaction was qualitatively assessed with a standard mammalian two-hybrid luciferase assay.\nThere was a significant impairment of mutated cTnI and cTnT protein interaction compared with wildtype control, whereas no change was recorded in mutated cTnI and cTnC.\nIn the N-terminus of cTnI, there are important interaction sites with both cTnC and cTnT. \nAdditionally, the N-terminus is highly conserved between species, and Ala2Val might lead to conformational changes of cTnI and hamper interaction with cTnT, ultimately leading to diminished muscle contraction.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15070570","rdfs:label":"standard mammalian two-hybrid luciferase assay","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/97c746af-c7d1-4dd2-8d2e-669909336bbd","type":"EvidenceLine","dc:description":"Autosomal recessive inheritance pattern with limited evidence","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0eebbcf-4b05-47ae-8a98-925c601a1c6c","type":"Finding","dc:description":"Alteration of the inhibitory activity of cTnI and cooperativity of activation of myofilament tension leads to abnormal cardiac myocyte contractility and eventually phenotypically manifests as DCM.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15070570","rdfs:label":"Biochemical function assessment","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c3fb91a1-46f1-4923-a7ed-24477873f159","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef7d8dd0-261c-4239-9c1a-15485a63116c","type":"FunctionalAlteration","dc:description":"The TNNI3:p.98trunc mutation from a 46-year-old male with DCM did not result in a truncated protein and instead caused haploinsufficiency leading to increased Ca2+-sensitivity and impaired length-dependent activation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28436080","rdfs:label":"assessment of Ca2+-sensitivity and length-dependent activ."}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/53272574-f725-46cd-80ad-0f3ee985baf8","type":"EvidenceLine","dc:description":"Already assigned this variant a functional evidence score based on Carballo et al. Since this study provides additional functional data, we score it for the evidence points, but to avoid overscoring of single variants/gene alterations in many functional studies, we reduced the score from the default 1.0 for functional alteration to 0.5","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b15fb7b3-f271-4787-99b6-57c33176078f","type":"FunctionalAlteration","dc:description":"TNNI3-Lys36Gln had faster relaxation kinetics. Passive stiffness was reduced. However, there was no change in maximum force (Figure 2B, D2 indicates TNNI3-Lys36Gln). \nThe decrease in myofibril passive stiffness was a common feature in all hearts with DCM-associated mutations and may be causative of DCM.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29093449","rdfs:label":"Cardiac myofibrils from TNNI3-Lys36Gln patients"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/105031c9-d581-4663-9ba2-c61cb2eb96fa","type":"EvidenceLine","dc:description":"Autosomal recessive inheritance pattern with limited evidence","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6774518b-b67e-46ee-8fce-27a076cb71b4","type":"FunctionalAlteration","dc:description":"In fibers regulated by the cTnI–Ala2Val mutation alone, there was a significantly decreased Hill coefficient (nH), a measure of the cooperativity of tension activation (Figure 8A).\nAnalysis of the ATPase rate of the skinned fiber bundles showed that in fibers controlled by cTnI–Ala2Val there was no effect on the Ca2+ sensitivity of ATPase activity, the Hill coefficient of the ATPase activity–pCa relation, or the maximum ATPase activity (Fig. 8B). \nAnalysis of the ATPase activity–tension relation, or tension cost, cTnI–Ala2Vala alone did not alter the relation compared to Wt (Fig. 8C).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15070570","rdfs:label":"skinned left ventricular papillary fiber bundles"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/14d356dc-453d-40c9-806f-dc3c317f1ea7","type":"EvidenceLine","dc:description":"Functional evidence considered similar to the Carballo et al. Therefore no additional points assigned.","calculatedScore":1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/406e2547-cb20-48c6-b960-e5ffffbe1aee","type":"FunctionalAlteration","dc:description":"TNNI3-Lys36Gln reduced myofilament Ca2+ sensitivity.\nIn thin filaments from normal human and mouse heart, protein kinase A (PKA) phosphorylation of troponin I caused a 2-3-fold decrease in myofibrillar Ca2+ sensitivity. \nHowever, Ca2+ sensitivity did not change with the level of troponin I phosphorylation in TNNI3-Lys36Gln. \nThis ‘uncoupling’ was observed with native mutant protein from human and mouse heart and with recombinant mutant protein expressed in baculovirus/Sf9 systems. \nUncoupling was independent of the fraction of mutated protein present above 0.55.\n\nConclusion: TNNI3-Lys36Gln abolishes the relationship between myofilament Ca2+ sensitivity and troponin I phosphorylation by PKA. The authors propose that this blunts the response to β-adrenergic stimulation and could be the cause of DCM in the long term.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23539503","rdfs:label":"Thin filaments containing human heart troponin with TnI K36Q"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/08453f1f-c3c2-4b5a-a881-e9f81793589a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a419d2d5-1378-4dc8-b5cb-3eb197ee399e","type":"FunctionalAlteration","dc:description":"Analysis of Ca2+ regulation of actin-tropomyosin–activated myosin ATPase by troponin revealed that troponin reconstituted with either mutant troponin I gave lower maximum ATPase rates and lower Ca2+ sensitivity than wild type. Furthermore, mutant thin filaments had reduced Ca2+ affinity compared with normal.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","rdfs:label":"in vitro characterization, E. coli"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d6b86810-6d06-4005-9720-4d421db012e4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/308efe9c-839a-42fd-8de3-610124ac1964","type":"FunctionalAlteration","dc:description":"the cTnI–Ala2Val mutation significantly decreased the slope of force-redevelopment-tension relations (Fig. 9B) and significantly increased the y-intercept of the relationship as compared to Wt.\nThus, Ala2Val increases the kinetics of force redevelopment at sub-maximal, but not maximal Ca2+ levels.\nConclusion: Myofilaments regulated by cTn–Ala2Val demonstrate altered cooperativity and kinetics of force redevelopment (ktr) dependent on pseudo-phosphorylation of S23/S24.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15070570","rdfs:label":"measurement of the ktr"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/473160ca-aec4-4a03-9180-35d547d1c8d6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ee6a9c3-5841-4ea0-81ba-1f62cefba808","type":"FunctionalAlteration","dc:description":"Analysis of Ca2+ regulation of actin-tropomyosin–activated myosin ATPase by troponin revealed that troponin reconstituted with either mutant troponin I gave lower maximum ATPase rates and lower Ca2+ sensitivity than wild type. \nFurthermore, mutant thin filaments had reduced Ca2+ affinity compared with normal.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19590045","rdfs:label":"in vitro characterization, E. coli"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/668087ea-0d2f-42c2-a291-f73400d34023_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c439f4e-6e33-4a17-87e6-7c2dc63ed8bb","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f74165b1-404d-449f-a770-fe314e699b1c","type":"Finding","dc:description":"Exchange with WT troponin complex restored cTnI levels in the TNNI3p.98trunc sample to 83% of that of controls exchanged with WT troponin complex.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28436080","rdfs:label":"Rescue of cTnI in human TNNI3.p.98trunc sample","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Strong","sequence":11511,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.45,"subject":{"id":"https://genegraph.clinicalgenome.org/r/1q1r7W11I5U","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:11947","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_668087ea-0d2f-42c2-a291-f73400d34023-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}